Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Subcutaneous ocrelizumab and hyaluronidase (Ocrevus Zunovo) was approved for relapsing and progressive multiple sclerosis, ...

Alzheimer's disease is becoming more prevalent due to lifestyle factors like inactivity, poor diet, loneliness, inadequate ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Alzheimer's disease primarily affects older adults, leading to cognitive decline. Preventive measures include a healthy ...

As the median age of our population rises, so does the number of people diagnosed with Alzheimer's disease. With advances in ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.